Skip to main content
Top
Published in: Internal and Emergency Medicine 8/2019

01-11-2019 | Myocardial Infarction | IM - ORIGINAL

Identifying patients with refusal of percutaneous coronary intervention for acute myocardial infarction: a classification and regression tree analysis

Authors: Manyan Wu, Long Li, Sufang Li, Yuxia Cui, Dan Hu, Junxian Song, Chongyou Lee, Hong Chen

Published in: Internal and Emergency Medicine | Issue 8/2019

Login to get access

Abstract

The purpose of the present study is to develop and validate a prediction tool to identify patients who refuse to receive percutaneous coronary intervention (PCI) rapidly. We developed a risk stratification model using the derivation cohort of 288 patients with ST segment elevation myocardial infarction (STEMI) in our hospital and validated it in a prospective cohort of 115 patients. There were 52 (18.1%) patients and 18 (15.7%) patients who refused PCI among derivation and validation cohort, respectively. A classification and regression tree (CART) analysis and multivariate logistic regression were used for statistical analysis. The decision-making factors for refusal of PCI were also investigated. The CART analysis and logistic regression both showed that self-rated mild symptom was the most significant predictor of not choosing PCI. The model generated three risk groups. The high-risk group included: self-rated mild symptoms; self-rated severe symptom, glomerular filtration rate < 60 ml/min/1.73m2. The intermediate-risk group included: self-rated severe symptom, glomerular filtration rate ≥ 60 ml/min/1.73m2 and age ≥ 75 years. The low-risk group included: self-rated severe symptom, glomerular filtration rate ≥ 60 ml/min/1.73m2 and age < 75 years. The prevalence for refusal of PCI of the three groups were 45%–44%, 18% and 4%, respectively. The sensitivity was 88% and the negative predictive value was 96%. And similar results were obtained when this prediction tool was applied prospectively to the validation cohort. Patients at low and high risk can be easily identified for refusal of PCI by the prediction tool using common clinical data. This practical model might provide useful information for rapid recognition and early response for this kind of crowd.
Appendix
Available only for authorised users
Literature
1.
go back to reference GBD (2017) Causes of Death Collaborators (2018) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392:1736–1788 GBD (2017) Causes of Death Collaborators (2018) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392:1736–1788
2.
go back to reference Benjamin EJ, Muntner P, Alonso A et al (2019) Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation 139:e56–e66CrossRef Benjamin EJ, Muntner P, Alonso A et al (2019) Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation 139:e56–e66CrossRef
3.
go back to reference Nguyen AV, Thanh LV, Kamel MG et al (2017) Optimal percutaneous coronary intervention in patients with ST-elevation myocardial infarction and multivessel disease: An updated, large-scale systematic review and meta-analysis. Int J Cardiol 244:67–76CrossRef Nguyen AV, Thanh LV, Kamel MG et al (2017) Optimal percutaneous coronary intervention in patients with ST-elevation myocardial infarction and multivessel disease: An updated, large-scale systematic review and meta-analysis. Int J Cardiol 244:67–76CrossRef
4.
go back to reference O'Gara PT, Kushner FG, Ascheim DD et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127:529–555CrossRef O'Gara PT, Kushner FG, Ascheim DD et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127:529–555CrossRef
5.
go back to reference Ibanez B, James S, Agewall S et al (2017) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39:119–177CrossRef Ibanez B, James S, Agewall S et al (2017) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39:119–177CrossRef
6.
go back to reference Windecker S, Kolh P, Alfonso F et al (2015) 2014 ESC/EACTS guidelines on myocardial revascularization. Euro Intervention 10:1024–1094PubMed Windecker S, Kolh P, Alfonso F et al (2015) 2014 ESC/EACTS guidelines on myocardial revascularization. Euro Intervention 10:1024–1094PubMed
7.
go back to reference Li J, Li X, Wang Q et al (2015) ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet 385:441–451CrossRef Li J, Li X, Wang Q et al (2015) ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet 385:441–451CrossRef
8.
go back to reference Xun YW, Yang JG, Song L et al (2010) In-hospital delay to primary angioplasty for patients with ST-elevated myocardial infarction between cardiac specialized hospitals and non-specialized hospitals in Beijing, China. Chin Med J (Engl) 123:800–805 Xun YW, Yang JG, Song L et al (2010) In-hospital delay to primary angioplasty for patients with ST-elevated myocardial infarction between cardiac specialized hospitals and non-specialized hospitals in Beijing, China. Chin Med J (Engl) 123:800–805
9.
go back to reference Zhou S, Chen J, Xu RY et al (2014) Factors associated with the use of percutaneous coronary intervention in elderly Chinese patients with a first ST elevated acute myocardial infarction. Patient Prefer Adherence 8:257–262PubMedPubMedCentral Zhou S, Chen J, Xu RY et al (2014) Factors associated with the use of percutaneous coronary intervention in elderly Chinese patients with a first ST elevated acute myocardial infarction. Patient Prefer Adherence 8:257–262PubMedPubMedCentral
10.
go back to reference Altamirano J, Lopez-Pelayo H, Michelena J et al (2017) Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: Prediction and impact on long-term survival. Hepatology 66:1842–1853CrossRef Altamirano J, Lopez-Pelayo H, Michelena J et al (2017) Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: Prediction and impact on long-term survival. Hepatology 66:1842–1853CrossRef
11.
go back to reference Odaka Y, Takahashi J, Tsuburaya R et al (2017) Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries. Eur Heart J 38:489–496PubMed Odaka Y, Takahashi J, Tsuburaya R et al (2017) Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries. Eur Heart J 38:489–496PubMed
12.
go back to reference Kattan MW (2010) Classification and regression trees versus nomograms: a bone scan positivity example. Eur Urol 57:559–561CrossRef Kattan MW (2010) Classification and regression trees versus nomograms: a bone scan positivity example. Eur Urol 57:559–561CrossRef
13.
go back to reference Lehmann G, Schmitt C, Kehl V et al (2003) Electrocardiographic algorithm for assignment of occluded vessel in acute myocardial infarction. Int J Cardiol 89:79–85CrossRef Lehmann G, Schmitt C, Kehl V et al (2003) Electrocardiographic algorithm for assignment of occluded vessel in acute myocardial infarction. Int J Cardiol 89:79–85CrossRef
14.
go back to reference Hochholzer W, Trenk D, Fromm MF et al (2010) Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement. J Am Coll Cardiol 55:2427–2434CrossRef Hochholzer W, Trenk D, Fromm MF et al (2010) Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement. J Am Coll Cardiol 55:2427–2434CrossRef
15.
go back to reference Thygesen K, Alpert JS, Jaffe AS et al (2012) Third universal definition of myocardial infarction. Circulation 126:2020–2035CrossRef Thygesen K, Alpert JS, Jaffe AS et al (2012) Third universal definition of myocardial infarction. Circulation 126:2020–2035CrossRef
16.
go back to reference Bahreini M, Jalili M, Moradi-Lakeh M (2015) A comparison of three self-report pain scales in adults with acute pain. J Emerg Med 48:10–18CrossRef Bahreini M, Jalili M, Moradi-Lakeh M (2015) A comparison of three self-report pain scales in adults with acute pain. J Emerg Med 48:10–18CrossRef
17.
go back to reference Rothberg MB, Sivalingam SK, Kleppel R et al (2015) Informed Decision Making for Percutaneous Coronary Intervention for Stable Coronary Disease. JAMA Intern Med 175:1199–1206CrossRef Rothberg MB, Sivalingam SK, Kleppel R et al (2015) Informed Decision Making for Percutaneous Coronary Intervention for Stable Coronary Disease. JAMA Intern Med 175:1199–1206CrossRef
18.
go back to reference Song JX, Zhu L, Lee CY, Ren H et al (2016) Total ischemic time and outcomes for patients with ST-elevation myocardial infarction: does time of admission make a difference? J Geriatr Cardiol 13:658–664PubMedPubMedCentral Song JX, Zhu L, Lee CY, Ren H et al (2016) Total ischemic time and outcomes for patients with ST-elevation myocardial infarction: does time of admission make a difference? J Geriatr Cardiol 13:658–664PubMedPubMedCentral
19.
go back to reference Fazel R, Krumholz HM, Bates ER et al (2009) Choice of reperfusion strategy at hospitals with primary percutaneous coronary intervention: a National Registry of Myocardial Infarction analysis. Circulation 120:2455–2461CrossRef Fazel R, Krumholz HM, Bates ER et al (2009) Choice of reperfusion strategy at hospitals with primary percutaneous coronary intervention: a National Registry of Myocardial Infarction analysis. Circulation 120:2455–2461CrossRef
20.
go back to reference Zhang SY, Hu DY, Sun YH et al (2008) Current management of patients with ST elevation myocardial infarction in Metropolitan Beijing, China. Clin Invest Med 31:E189–E197CrossRef Zhang SY, Hu DY, Sun YH et al (2008) Current management of patients with ST elevation myocardial infarction in Metropolitan Beijing, China. Clin Invest Med 31:E189–E197CrossRef
21.
go back to reference Gao R, Patel A, Gao W et al (2008) Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart 94:554–560CrossRef Gao R, Patel A, Gao W et al (2008) Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart 94:554–560CrossRef
22.
go back to reference Schiele F, Hochadel M, Tubaro M et al (2010) Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction. Eur Heart J 31:2614–2624CrossRef Schiele F, Hochadel M, Tubaro M et al (2010) Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction. Eur Heart J 31:2614–2624CrossRef
23.
go back to reference de Boer SP, Barnes EH, Westerhout CM et al (2011) High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaboration. Am Heart J 161:500–507CrossRef de Boer SP, Barnes EH, Westerhout CM et al (2011) High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaboration. Am Heart J 161:500–507CrossRef
24.
go back to reference Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361:13–20CrossRef Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361:13–20CrossRef
25.
go back to reference Stone GW (2008) Angioplasty strategies in ST-segment-elevation myocardial infarction: part I: primary percutaneous coronary intervention. Circulation 118:538–551CrossRef Stone GW (2008) Angioplasty strategies in ST-segment-elevation myocardial infarction: part I: primary percutaneous coronary intervention. Circulation 118:538–551CrossRef
26.
go back to reference Dong S, Chu Y, Zhang H et al (2014) Reperfusion times of ST-Segment elevation myocardial infarction in hospitals. Pak J Med Sci 30:1367–1371CrossRef Dong S, Chu Y, Zhang H et al (2014) Reperfusion times of ST-Segment elevation myocardial infarction in hospitals. Pak J Med Sci 30:1367–1371CrossRef
27.
go back to reference Eagle KA, Goodman SG, Avezum A et al (2002) Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 359:373–377CrossRef Eagle KA, Goodman SG, Avezum A et al (2002) Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 359:373–377CrossRef
28.
go back to reference Avezum A, Makdisse M, Spencer F et al (2005) Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 149:67–73CrossRef Avezum A, Makdisse M, Spencer F et al (2005) Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 149:67–73CrossRef
29.
go back to reference Gharacholou SM, Alexander KP, Chen AY et al (2010) Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRUSADE initiative. Am Heart J 159:757–763CrossRef Gharacholou SM, Alexander KP, Chen AY et al (2010) Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRUSADE initiative. Am Heart J 159:757–763CrossRef
30.
go back to reference Hall M, Laut K, Dondo TB et al (2014) Patient and hospital determinants of primary percutaneous coronary intervention in England, 2003–2013. Heart 102:313–319CrossRef Hall M, Laut K, Dondo TB et al (2014) Patient and hospital determinants of primary percutaneous coronary intervention in England, 2003–2013. Heart 102:313–319CrossRef
31.
go back to reference Ranasinghe I, Rong Y, Du X et al (2014) System barriers to the evidence-based care of acute coronary syndrome patients in China: qualitative analysis. Circ Cardiovasc Qual Outcomes 7:209–216CrossRef Ranasinghe I, Rong Y, Du X et al (2014) System barriers to the evidence-based care of acute coronary syndrome patients in China: qualitative analysis. Circ Cardiovasc Qual Outcomes 7:209–216CrossRef
32.
go back to reference Hochman JS, Sleeper LA, White HD et al (2001) One-year survival following early revascularization for cardiogenic shock. JAMA 285:190–192CrossRef Hochman JS, Sleeper LA, White HD et al (2001) One-year survival following early revascularization for cardiogenic shock. JAMA 285:190–192CrossRef
Metadata
Title
Identifying patients with refusal of percutaneous coronary intervention for acute myocardial infarction: a classification and regression tree analysis
Authors
Manyan Wu
Long Li
Sufang Li
Yuxia Cui
Dan Hu
Junxian Song
Chongyou Lee
Hong Chen
Publication date
01-11-2019
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 8/2019
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02079-3

Other articles of this Issue 8/2019

Internal and Emergency Medicine 8/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.